KLRB1 and rheumatoid arthritis: These CD3+ CD161+ lymphocytes are potent mediators of inflammation, and have been linked with chronic inflammatory diseases such as rheumatoid arthritis and correlate with disease severity in rheumatoid arthritis [39,40].